Time to Spare Newly Diagnosed Non Transplant Eligible Myeloma from Thalidomide
Denis Caillot, Hélène Demarquette(Ikerbasque), Laurent Garderet(Inserm), Lionel Karlin(Hôpital Lyon Sud), Francesca Gay(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Katell Le Dû(Clinique Victor Hugo), Evangelos Terpos(National and Kapodistrian University of Athens), Xavier Leleu(Inserm), Laurent Voillat, Muriel Newingerm(Maison des Sciences sociales et des Humanités de Dijon), Brigitte Pegourié(Centre Hospitalier Universitaire de Grenoble), Niels Abildgaard(University of Southern Denmark), Laurence Legros(Hôpital l'Archet), Margaret Macro(Hôpital Cochin), Lotfi Benboubker, Martine Escoffre‐Barbe(Université Rennes 2), Bruno Royer(Centre Hospitalier Universitaire Amiens-Picardie), Sonja Zweegman(Vrije Universiteit Amsterdam), Souhila Ikhlef(Sorbonne Université), C. Vieira dos santos, Cyrille Hulin(Hôpital Cardiologique du Haut-Lévêque), Philippe Moreau(Centre National de la Recherche Scientifique), Eva de Jongh(Albert Schweitzer Ziekenhuis), Anne‐Marie Stoppa(Institut Paoli-Calmettes), Anne Banos(Centre Hospitalier de la Côte Basque), Claire Bories(Guy's and St Thomas' NHS Foundation Trust), Éric Voog(Centre Jean Bernard), Artur Jurczyszyn(Jagiellonian University), Thierry Façon(Université de Lille)
Cited by 0
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Hematological findings and complications of <scp>COVID</scp>‐19
|American Journal of Hematology|2020|1.7k
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
|New England Journal of Medicine|2020|1.5k